The aim of this research project is to have a better understanding of vaccine hesitancy and safety concerns among healthcare vaccine providers and their patients in Europe and to explore the link and potential influence between the two groups.
This report presents the results of a systematic literature review investigating the impact of novel strategies and approaches (using existing and/or novel testing technologies) on access to testing, testing coverage, and linkage to care of key populations at-risk for sexually transmitted infections (STIs).
Several countries affected by the coronavirus disease (COVID-19) pandemic recently reported cases of children that were hospitalised in intensive care due to a rare paediatric inflammatory multisystem syndrome (PIMS). The presenting signs and symptoms are a mix of the ones for Kawasaki disease (KD) and toxic shock syndrome (TSS) and are characterised, among others, by fever, abdominal pain and cardiac involvement. A possible temporal association with SARS-COV-2 infection has been hypothesised because some of the children that were tested for SARS-CoV-2 infection were either positive by polymerase chain reaction (PCR) or serology.
This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
Helping parents to understand vaccination and supporting their choice to get their children protected is one of the most important aspects of the work of a primary healthcare professional.
The Burden of Communicable Disease in Europe (BCoDE) toolkit is a stand-alone software application which allows calculation of disability-adjusted life years (DALYs) for a selection of 117 communicable diseases and six healthcare-associated infections.
This final project component identifies the future strategic actions required for strengthening capacity in Europe to develop evidence-informed health communication for communicable diseases.
This literature review examines the published evidence on the effectiveness of European promotional communications for national immunisation schedule vaccinations.
The objective of this report is to systematically review the evidence on active case finding in prison settings, with a focus on the European Union (EU) and the European Economic Area (EEA) region.
This document is an update of the joint guidance that was published in 2011 by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).